SEC Comment Letter for HOULIHAN LOKEY, INC. (HLI) (CIK 0001302215) (HLI) — Jun 5, 2015
HOULIHAN LOKEY, INC. (HLI) (CIK 0001302215)
Date: June 5, 2015 · CIK: 0001302215 · Accession: 0000000000-15-030025
AI Filing Summary & Sentiment
Show Raw Text
June 4, 2015 Via E -Mail Christopher M. Crain, Esq. General Counsel Houlihan Lokey, Inc. 10250 Constellation Blvd., 5th Floor Los Angeles, CA 90067 Re: Houlihan Lokey, Inc. Draft Registration Statement on Form S-1 Submitted May 8, 2015 CIK No. 0001302215 Dear Mr. Crain : We have reviewed your draft registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe our comments apply to your facts and circumst ances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to these comments and your amended draft registration statement or filed registration statement, we may have additional comments. General 1. Please provide us with copies of any graphical materials or artwork, including logos, that you intend to use in your prospectus. Please refer to Question 101.02 of our Compliance and Disclosure Interpretations (Securities Act Forms) for guidance. 2. Please supplementally provide us with copies of all written communications, as defined in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf, present to potential investors in reliance on Section 5(d) of the Securities Act, whether or not they retain copies of the communications. Similarly, please supplementally provide us with any research reports about you that are published or distributed in reliance on Section 2(a)(3) of th e Securities Act by Section 105(a) of the Christopher M. Crain , Esq. Houlihan Lokey, Inc. June 4, 2015 Page 2 Jumpstart Our Business Startups Act by any broker or dealer that is participating or will participate in your offering. Overview, page 1 3. We note your statement that you achieved compound annual growth rates of 8.8% and 9.7% in revenues and net income, respectively, from 2000 to 2014. We also note that, in this passage and throughout your prospectus, you refer to your revenues as stable and predictable, both as compared to your competitors and generally. Pleas e expand your disclosure as applicable to note any years in which your revenue and/or net income significantly diverged from these historical averages. Our Services, page 4 4. We note your statement here, and elsewhere, that you receive upfront and month ly retainer fees in a majority of your Corporate Finance and Financial Restructuring engagements. We also note that on page 22 you state that for advisory engagements that do not result in the successful consummation of a transaction, you sometimes receiv e a “modest retainer.” Finally, we note that, while you received retainer and/or progress fees for 89% of your financial restructuring engagements, they combined to account for only 29% of your revenues in fiscal 2014. Please consider revising this discl osure to include information about the relative contribution that these types of fees make to your overall revenues. 5. You state that your ability to provide customized capital markets solutions in the private capital markets differentiates you from bulg e-bracket firms that focus on competing in more standardized and commoditized financings. Please expand your disclosure to briefly describe the role or roles that you play in these types of private capital market transactions. Our Market Opportunity, pag e 7 Growth in Corporate Debt Issuance and Rise in Restructuring Activity, page 8 6. We note your statement that a spike in default rates often follows periods of substantial leveraged loans and high yield issuances, which you indicate that you expect to occur even if the macroeconomic environment continues to improve. We also note that the past two such spikes, as illustrated in your chart on page 9, occurred in proximity to U.S. economic recessions. Please reconcile these statements, along with your s tatements elsewhere (for example, on page 7) that the U.S. macroeconomic environment is stabilizing and the market is returning to higher levels. Christopher M. Crain , Esq. Houlihan Lokey, Inc. June 4, 2015 Page 3 Summary Consolidated Financial and Other Data, page 18 7. We note that you have presented your financial data within the front part of the document based on the oldest periods displayed first, but in your consolidated financial statements, you have presented the most current data presented first. Please revise your chronological ordering of data to be consis tently presented throughout the entire document. Please refer to SAB Topic 11:E. Risk Factors, page 20 General 8. A number of your risk factors discuss risk in generic terms, without providing the investor with an indication of the likelihood that the risk may occur or the potential impact of the risk on your financial condition. For instance, on page 27 you discuss the risk that your clients may not be able to pay you for your services. How many clients have failed to pay their bills in each of the l ast two fiscal years and what was the total amount of fees that remain uncollected due to default? Also, how much of your earned fees are currently unpaid by your clients? Similarly, on page 28 you discuss the potential impact of operational risks. Have you suffered any significant losses or other damages as a result of operational risks, or has your controls testing indicated that you have a significant deficiency? Revise all your risk factors so that they provide the investor with an idea of the likel ihood that a risk may impact your results and the potential impact on your assets and earnings. For instance, please review the first risk factor on page 24, the last risk factor on page 26, the last risk factor on page 28 and the first risk factor on pag e 29. We may not be able to generate sufficient cash in the future to service any future indebtedness, page 27 9. Please revise this risk factor to indicate that you have current plans to incur indebtedness in connection with the offering. Corporate Reorganization , page 40 10. In order for investors to better understand the change in your organizational structure as you transition to a public company, consider providing a graphical presentation of the current corporate structure and the corporate str ucture after the reorganization and offering. The presentation should also clarify which assets will be added to Houlihan Lokey and the assets which will be distributed to ORIX USA and the other current owners of the existing entity prior to the offering. 11. You state that prior to the consummation of this offering, you will make a distribution to your existing owners consisting of cash and certain of your non -operating assets. We Christopher M. Crain , Esq. Houlihan Lokey, Inc. June 4, 2015 Page 4 also note per page 53 that your non -operating minority investment in an engineering business will be distributed among other assets, to the existing owners of Houlihan Lokey as part of the corporate reorganization. Please clarify which assets, including the related carrying value, will be include in the distribution to your e xisting owners. Additionally, in light of this distribution and other reorganization transactions occurring, please tell us how you concluded that pro forma financial statements prepared in accordance with Article 11 of Regulation S -X were not required. 12. We note from your discussion of your 2006 Incentive Compensation Plan on page 96, that in connection with the corporate reorganization, outstanding restricted stock granted pursuant to the 2006 Plan will convert into restricted shares of Class B common stock. Please enhance and clarify in your “Corporate Reorganization” and “Effects of the Corporate Reorganization and this Offering” discussions how the conversion of outstanding restricted stock granted under the 2006 Incentive Plan will be effected. 13. We note from you disclosure on page F -14, that ORIX USA has the right, but not the obligation, to purchase shares to maintain its majority effective ownership of the Company and that historically it has exercised this right. Please clarify whether ORI X USA will maintain the right, post corporate reorganization to maintain its effective ownership of the Company. Capitalization, page 43 14. We note that you have included Receivable from affiliates in your capitalization table. Please explain the basi s thereof and tell us whether this line item is expected to be affected by any pro forma adjustments. Management’s Discussion and Analysis of Financial Condition and Results of Operations, page 48 Business Environment and Outlook, page 49 15. We note yo ur statement here, and elsewhere in the registration statement, that demand for your financial restructuring services remains “reasonably strong.” Please expand your disclosure to clarify what the benchmark for this comparison is (i.e. as compared to your performance in prior years, or, alternatively, as compared to your peer companies, for example). We note that revenues and earnings for the nine month period ending December 31, 2014 declined compared to the prior year period. 16. In your Overview discu ssion on page 1 you state that Houlihan Lokey is a leading global independent investment bank with 17 offices globally and on page 25 your disclose that 14% of your revenue was earned from international operations. Please enhance your Fee Revenue discussio n on page 49 to disclose fees earned from your international Christopher M. Crain , Esq. Houlihan Lokey, Inc. June 4, 2015 Page 5 operations, including by business segment, as applicable, for the respective periods presented. Additionally, to the extent that any specific countries account for the majority of the internatio nal revenue, please disclose those countries. Key Financial Measures, page 49 Operating Expenses; Employee Compensation and Benefit Expenses, page 50 17. Please revise this section, or another appropriate portion of your Management’s Discussion and Analysis, to discuss any reason why compensation expense appears to rise faster than your revenues, but also will decline faster than revenues contract. For instance, we note that overall compensation expenses increased 19% in the year ended March 31, 2014 compared to the prior year, and 20% in in the nine month period ending December 31, 2014 compared to the same period in 2013. However, Fee revenue increased 1 4% and 19% over the same periods. Conversely, when revenues for your restructuring unit declined in the nine month period ending December 31, 2014 compared to 2013, compensation declined 25%. 18. In your discussion of employee compensation and benefits expenses, you state that your existing arrangements with your affiliate, ORIX USA, will terminate and that your compensation and benefits expenses to fee revenue has been higher than what you intend to target. You also state that you plan to target a com pensation ratio of approximately 65% to 66%. Please clarify if your target compensation ratio is calculated based on compensation and benefits expenses to fee revenue and revise your discussion to disclose what the ratio has been for the periods presented . Business Segments, page 53 Corporate Finance, page 54 19. We note your table on page 55 of U.S. M&A market and M& A transaction information specific to Houlihan Lokey based on Thomson Reuters reporting. In the table and the discussion following the table you state that U.S. M&A transactions announced and completed increased 6% and 3%, respectively compared with the y ear ended March 31, 2013 and the number of U.S. M&A transactions announced and completed for the nine months ended December 31, 2014 increased 10% and 6%, respectively, compared with the nine months ended December 31, 2013. However, these changes do not c orrespond with the number changes shown in the table. Specifically, it appears that either the percentage changes all have the wrong signs, or that the data in the table is incorrectly included in the wrong column of the table. Please revise the tables an d/or percentages accordingly, along with the qualitative discussion on page 56 related to your analysis of your segment results. Christopher M. Crain , Esq. Houlihan Lokey, Inc. June 4, 2015 Page 6 20. We note your disclosure on page 56 that during the year ended March, 31, 2014 versus March 31, 2013, you experienced a 1 9.6% increase in your average fee for closed corporate finance transactions, and that for the nine months ended December 31, 2014 versus the nine months ended December 31, 2013, you experienced a 29% increase in your average fee for the closed corporate fi nance transactions. Please clarify how this percentage increase is calculated and discuss the drivers of the increase in the average fee. To the extent there are any known trends or uncertainties regarding the continued growth in the average fee rate, pl ease discuss them. Corporate Revenues and Expenses, page 59 21. We note from your disclosure that corporate expenses increased by 38% for the year ended March 31, 2014 compared to the year ended March 31, 2013, and increased an additional 23% during the nine months ended December 31, 2014 compared to the nine months ended December 31, 2013. In both cases, your disclosure indicates that the increase in these expenses was primarily a result of increased compensation costs to corporate employees. Please ex pand your disclosure to provide the underlying drivers (e.g. increase in number of employees, nature of the employees’ functions, nature of benefits offered, etc.) of these compensation increases for each period presented. Liquidity and Capital Resourc es, page 60 22. We note that you loan excess cash on hand to ORIX USA and that you intend to continue your current cash management processes. Please expand this disclosure to provide a general description of the terms of this arrangement, including a dis cussion of any collateral provided to secure these loans and any other types of recourse that you have against ORIX USA in the case of nonpayment. 23. We note from your discussion that a significant use of your cash is your loan receivable from ORIX USA. Enhance your discussion to address how the impact of this offering, related reorganization and agreements will impact this lending arrangement with ORI X USA and the related impact to your liquidity, including any expected changes in uses and sources of liquidity. Refer to Item 303(A)(1) of Regulation S -K. 24. We note that for the periods ending March 31, 2014, and 2013 and the nine months ending Dece mber 31, 2014 and 2013, you paid cash dividends to your stockholders. Enhance your discussion to address how you expect both the corporate reorganization and this offering to impact this trend. Refer to Item 303(A)(1) of Regulation S -K. Contractual Obli gations, page 62 25. We note that in conjunction with your minority investment in an unconsolidated entity call and put rights were issued each at a multiple of the prior twelve months net income Christopher M. Crain , Esq. Houlihan Lokey, Inc. June 4, 2015 Page 7 times the percentage of ownership being acquired or sold. Please revise your Summary of Significant Accounting Policies to disclose your accounting policy for the options and tell us how you have determined the value of the options. Critical Accounting Policies and Estimates, page 63 Recognition of Revenue, pa ge 63 26. Disclose the specific method you use to measure the estimates of work completed under the proportional revenue methodology. Additionally, discuss the estimates and assumptions involved in evaluating the profitability and stage of completion of projects. 27. Your disclosu